Aardvark Mobile Health, a division of experiential marketing company, Aardvark Mobile Tours, has pivoted in the pandemic to create fleets of state-of-the-art vehicles as an alternative to current vulnerable testing facilities and a new way to screen potential carriers of the virus.
The two patented trucks are uniquely designed to serve multiple purposes. The Aardvark testing trucks can quickly be deployed for safer and more efficient testing of underserved communities and hot spots while the Aardvark screening trucks are designed to conduct temperature checks and additional symptomatic screenings of people prior to entering any location with a large gathering such as office buildings, warehouses, military bases, convention centers, and sporting arenas in order to mitigate the risk of COVID-19 spread.
Aardvark Mobile Tours led innovation in the mobile retail landscape by allowing large brands such as Coca Cola and Nike to insert themselves into new markets and get in front of new customers. At the onset of the pandemic, founder and CEO Larry Borden realized he had the opportunity to do the same with testing and screening by providing the means for pharmacies, workplaces, event venues and more to meet people where they are. Aardvark Mobile Health aims to prioritize public health by assisting organizations with scalable and easy-to-access care.
June 23, 2020
Topic Area: Press Release
Recent Posts
Disinfectant Dispensers in Healthcare Facilities Often Fail to Deliver Safe Concentrations: Study
Study of 10 hospitals finds 90 percent have at least one dispenser delivering disinfectants at incorrect concentrations.
Duke University Health System Receives $50 Million for Proton Beam Therapy Center
The donation is the largest philanthropic gift received by Duke University Health System.
Protecting Patient Data: Strategies and Tactics
As cyber threats and breaches grow, healthcare organizations and facilities need a better approach to cybersecurity.
Duke Health to Acquire Lake Norman Regional Medical Center
The closing is projected for the first quarter of 2025.